SERPINH1 and deltaretrovirus infections: These results were demonstrated by a future study in 2016; it revealed that Anti-HTLV-1 gp46 neutralizing monoclonal antibody (LAT-27) could have potential for passive immunization against HTLV infection in both vertical and horizontal spread HTLV-1 (54).